There is growing evidence from epidemiological studies and clinicopathological data obtained from case reports that Crohn's disease is associated with an increased risk of carcinoma of the small and large bowel. In contrast with ulcerative colitis where the risk of colorectal carcinoma is clearly established, the extent of the risk in Crohn's disease remains controversial. Four population based studies have failed to show an increase in the incidence of any type of cancer, including colorectal carcinoma, in patients with Crohn's disease.A4 One population study,5 a national survey of 95 American gastroenterologists, 6 and three other large series from tertiary referral centres7-9 describe an increased comparative risk of colorectal cancer in patients with Crohn's disease ranging from 2 Ito 20 0.
Three of four referral based studies have also described an increased incidence of small intestinal cancers in Crohn's disease. 68 The remaining report found no such excess but more gastric carcinomas were found than expected. 9 In addition, there have been three longterm analyses of the overall incidence of extraintestinal cancers in Crohn's disease and in none has an excess been found,>" although increases in squamous cell cancer''" and lymphomas" 12 have been reported.
Among the many reports of bowel tumours in Crohn's disease, there have been few describing carcinoma of the anorectal region, anus or in association with anal or rectal fistulas.' 13- 12-96). One patient with a five year history of essential thrombocytosis was receiving hydroxyurea when cancer was diagnosed (Table I: case 9). The tumour was found by an examination under anaesthetic in three patients; in two others this examination was negative within a year of the diagnosis of malignancy.
Of seven patients with adenocarcinoma of the lower third of rectum, the pathology specimen was available for review in six. One tumour affected a perirectal sinus, two were associated with fistulas, and three were highly invasive adencarcinomas that disorganised the surrounding architecture. The specimen in which malignancy affected a perirectal sinus exhibited high grade dysplasia along the sinus and a concomitant carcinoma arising from a villous adenoma of the mid rectum. High grade dysplasia was also detected along the fistulous tracts of two other patients whose rectal malignancy were affected fistulas. Five of the carcinomas were mucinous. One was staged Dukes's A, six Dukes's B, and one Dukes's C. All patients had surgical treatment of the tumour, which included proctocolectomy in five, proctectomy in two, and a synchronous combined excision in one. Two patients survived five years or more, four died within five years of cancer detection, and one remains alive 12 months postoperatively.
CARCINOMA OF THE ANUS
Five patients developed squamous cell carcinoma of the anal canal, one of which affected an Table I. anal skin tag. Three patients were female. The mean age of cancer detection was 52 years and all patients had chronic disease affecting the anorectal region (mean duration 18 years). Two patients had fistulas affecting the anus and rectum, one had a chronic anorectal stricture, one a persistent perianal abscess, and one had grossly enlarged skin tags. All patients had been reasonably well despite grossly distorted anatomy until they reported increasing anorectal symptoms three to six months before the diagnosis of malignancy. Except for one patient who complained of an anal lump, these symptoms were similar to those seen in the patients with rectal cancer who have already been described. The patient with oedematous anal skin tags complained ofincreasing pain and bleeding related to the tags before surgery. Two patients had been treated with azathioprine. The diagnosis of malignancy was established at examination under anaesthetic in four cases and by histological examination of the excised anal skin tag in another.
Treatment was surgical in all but the most recent case where chemoradiotherapy was performed (Table I: case 14) . In one patient the tumour was inoperable (Table I: case 13) but the operation was a radical procedure in the other three patients. The operative specimen contained Bowen's disease in two cases. Except for the patient with an inoperable tumour who died eight months postoperatively, two patients survived more than five years and two others remain alive six months and three years respectively after treatment for cancer. As the patient who received chemoradiotherapy has been followed up for only a short period, it is premature to assess the efficacy of this treatment in anal cancer related to Crohn's disease.
Discussion
The first reported case of colorectal carcinoma in a patient with Crohn's disease was described by Warren 34 35 and, overall, the prognosis is much poorer. 35 Rectal cancer occurring in Crohn's disease is well recognised but less attention has been given to carcinoma developing in the anal region, lower rectum or in association with anal or rectal fistulas. Only 28 such cases have been described,9 1-27 eight previously reported from this hospital. 13 
